




Searching News Database: Sinusitis
HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
HSMN NewsFeed - 1 Dec 2020
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
HSMN NewsFeed - 30 Jan 2017
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
HSMN NewsFeed - 20 Jul 2016
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
HSMN NewsFeed - 10 Nov 2015
Teva Canada Announces the Launch of PrTeva-Moxifloxacin Tablet, a generic of PrAvelox(R)
Teva Canada Announces the Launch of PrTeva-Moxifloxacin Tablet, a generic of PrAvelox(R)
HSMN NewsFeed - 13 Feb 2015
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
HSMN NewsFeed - 25 Jul 2013
Study Shows Benefits of Balloon Sinus Dilation versus Traditional Sinus Surgery for Chronic Sinusitis
Study Shows Benefits of Balloon Sinus Dilation versus Traditional Sinus Surgery for Chronic Sinusitis
HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
HSMN NewsFeed - 12 Mar 2012
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
HSMN NewsFeed - 14 Nov 2011
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
HSMN NewsFeed - 23 Sep 2011
Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors
Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors
HSMN NewsFeed - 12 Sep 2011
Entellus Medical Launches PathAssistTM Light SeekerTM to Help ENT Physicians Navigate Frontal Sinus Passages
Entellus Medical Launches PathAssistTM Light SeekerTM to Help ENT Physicians Navigate Frontal Sinus Passages
HSMN NewsFeed - 23 Feb 2011
Entellus Medical(TM) Receives FDA 510(k) Clearance for FinESS(TM) Endoscope
Entellus Medical(TM) Receives FDA 510(k) Clearance for FinESS(TM) Endoscope
HSMN NewsFeed - 28 Apr 2010
Entellus Medical(R) Launches the XprESS Multi-Sinus Dilation Tool at COSM 2010 Annual Meeting
Entellus Medical(R) Launches the XprESS Multi-Sinus Dilation Tool at COSM 2010 Annual Meeting
HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
HSMN NewsFeed - 4 May 2009
Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
HSMN NewsFeed - 13 Jan 2009
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
HSMN NewsFeed - 3 Nov 2008
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
HSMN NewsFeed - 22 Sep 2008
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
HSMN NewsFeed - 6 May 2008
Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted for Review by FDA
Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted for Review by FDA
HSMN NewsFeed - 15 Apr 2008
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
HSMN NewsFeed - 22 Feb 2008
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
HSMN NewsFeed - 19 Jan 2008
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
HSMN NewsFeed - 16 Oct 2007
Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
HSMN NewsFeed - 27 Sep 2007
Critical Therapeutics and Dey Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets
Critical Therapeutics and Dey Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets
HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
HSMN NewsFeed - 5 Sep 2007
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
HSMN NewsFeed - 16 Jul 2007
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
HSMN NewsFeed - 31 May 2007
FDA Approves Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma
FDA Approves Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma
HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
HSMN NewsFeed - 16 Apr 2007
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
HSMN NewsFeed - 2 Apr 2007
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
HSMN NewsFeed - 27 Feb 2007
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
HSMN NewsFeed - 26 Dec 2006
Faropenem Phase III Clinical Trial Stopped to Consider Exclusion of Ketek Comparator
Faropenem Phase III Clinical Trial Stopped to Consider Exclusion of Ketek Comparator
HSMN NewsFeed - 21 Dec 2006
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
HSMN NewsFeed - 22 Nov 2006
OctoPlus Grants Green Cross Corporation Exclusive Korean License to OP-145 for Chronic Middle ear Infection
OctoPlus Grants Green Cross Corporation Exclusive Korean License to OP-145 for Chronic Middle ear Infection
HSMN NewsFeed - 13 Nov 2006
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
HSMN NewsFeed - 23 Oct 2006
U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem
U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem
HSMN NewsFeed - 5 Oct 2006
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of FACTIVE(R) Tablets in Mexico
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of FACTIVE(R) Tablets in Mexico
HSMN NewsFeed - 19 Sep 2006
Multi-Center Study Confirms Balloon Sinuplasty(TM) Technology Is Safe and Effective
Multi-Center Study Confirms Balloon Sinuplasty(TM) Technology Is Safe and Effective
HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
HSMN NewsFeed - 11 May 2006
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Additional items found! 151

Members Archive contains
151 additional stories matching:
Sinusitis
(Password required)
Sinusitis
(Password required)